In silico Analysis of CHD4 Mutations Reveals Domain-Specific Impacts on Cardiovascular Disorders Among Patients With Rare Diseases.
WHY IT MATTERS
This research provides a framework for doctors to predict how specific CHD4 mutations will affect individual patients' hearts and blood vessels, potentially improving diagnosis and treatment planning for rare conditions like Sifrim-Hitz-Weiss syndrome and moyamoya angiopathy.
Scientists studied how different mutations in the CHD4 gene affect the heart and blood vessels in patients with rare diseases. CHD4 is a protein that helps control how genes are turned on and off in cells. By using computer analysis, researchers found that mutations in different parts of this protein cause different types of heart and vessel problems, which could help doctors better understand and classify these genetic conditions.
In silico Analysis of CHD4 Mutations Reveals Domain-Specific Impacts on Cardiovascular Disorders Among Patients With Rare Diseases. Abstract: Chromodomain-helicase-DNA-binding protein 4 (CHD4) is a critical ATP-dependent chromatin remodeler that plays fundamental roles in transcriptional repression, DNA damage repair, and lineage specification, making it indispensable for cardiovascular development and function. Pathogenic CHD4 mutations are linked to syndromic and nonsyndromic conditions, often presenting with severe cardiac and vascular anomalies. However, most of these mutations are unique and nonrecurrent, complicating variant classification. In this study, we establish a connection between recent advances in CHD4 structure and function and 36 pathogenic CHD4 mutations associated with rare diseases, including Sifrim-Hitz-Weiss syndrome, moyamoya angiopathy, and childhood idiopathic epilepsy with sinus arrhythmia, all of whic Authors: Novillo et al. Journal: Human mutation MeSH: Humans, Mi-2 Nucleosome Remodeling and Deacetylase Complex, Mutation, Cardiovascular Diseases, Rare Diseases, Computer Simulation, Genetic Predisposition to Disease, Protein Domains, Computational Biology
ASK YOUR DOCTOR
If you or your child has been diagnosed with a CHD4-related condition, ask your cardiologist whether this domain-specific mutation analysis has been applied to your genetic test results to better understand your specific cardiac risks.